Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinomaMelanie Ruf, Christiane Mittmann, Anna M Nowicka, et al.Brain : a Journal of Neurology|February 5, 2013
Integrin control of the transforming growth factor-β pathway in glioblastomaPatrick Roth, Manuela Silginer, Simon L Goodman, et al.International Journal of Oncology|November 18, 2004
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia, Peter Schraml, Ronald Simon, et al.Communications Medicine|January 5, 2024
Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumorsMart van Rijthoven, Simon Obahor, Fabio Pagliarulo, et al.International Journal of Molecular Sciences|October 14, 2022
Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer CellsMostafa A Aboouf, Julia Armbruster, Markus Thiersch, et al.Plos Computational Biology|December 15, 2021
Statistical tests for intra-tumour clonal co-occurrence and exclusivityJack Kuipers, Ariane L Moore, Katharina Jahn, et al.Carcinogenesis|November 25, 2010
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cellsKai Doberstein, Anja Wieland, Sophia B Boyoung Lee, et al.Nature Cell Biology|July 22, 2009
VHL loss causes spindle misorientation and chromosome instabilityClaudio R Thoma, Alberto Toso, Katrin L Gutbrodt, et al.The American Journal of Pathology|July 19, 2011
Relevance of periostin splice variants in renal cell carcinomaLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.Cancer Immunology Research|April 30, 2014
Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinomaStefanie R Dannenmann, Thomas Hermanns, Ali Bransi, et al.Pageof 12